Infinimmune operates as a biotechnology company.
Infinimmune operates as a biotechnology company. Infinimmune reinvents antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 6, 2022 | Seed | $12M | 9 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Seed |
![]() |
— | Seed |
![]() |
— | Seed |
![]() |
— | Seed |
![]() |
— | Seed |
![]() |
— | Seed |
![]() |
— | Seed |
|
— | Seed |
![]() |
— | Seed |